Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Neely

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
Current HIV/AIDS Reports|August 11, 2005
Management of antiretroviral therapy in neonates, children, and adolescentsMichael Neely, Andrea Kovacs
Mycoses|October 14, 2009
Incidence and predictors of invasive candidiasis associated with candidaemia in childrenAra Festekjian, Michael Neely
Current Infectious Disease Reports|December 3, 2003
Management of Antiretroviral Therapy in Neonates, Children, and AdolescentsMichael Neely, Andrea Kovacs
Clinical Pharmacokinetics|November 18, 2011
Obesity and its impact on drug therapy: are we ready for this change?Michael Neely, Stan Louie
Journal of Clinical Pharmacology|July 19, 2008
Practical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimizationMichael Neely, Roger Jelliffe
Therapeutics and Clinical Risk Management|August 27, 2009
Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavirMichael Neely, Andrea Kovacs
Current Therapeutic Research, Clinical and Experimental|June 20, 2014
Pharmacokinetic characteristics of caspofungin in two pediatric liver transplant patientsMichael Neely, Jeffrey Blumer
Journal of Clinical Pharmacology|February 16, 2010
Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometricianMichael Neely, Roger Jelliffe
Journal of Pharmacokinetics and Pharmacodynamics|December 3, 2016
Experiment design for nonparametric models based on minimizing Bayes Risk: application to voriconazole¹David S Bayard, Michael Neely
The Annals of Pharmacotherapy|August 25, 2011
Comment: assessment of vancomycin dosing and subsequent serum concentrations in pediatric patientsSylvain Goutelle, Michael Neely, Nathalie Bleyzac
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
Current HIV/AIDS Reports|August 11, 2005
Management of antiretroviral therapy in neonates, children, and adolescentsMichael Neely, Andrea Kovacs
Mycoses|October 14, 2009
Incidence and predictors of invasive candidiasis associated with candidaemia in childrenAra Festekjian, Michael Neely
Current Infectious Disease Reports|December 3, 2003
Management of Antiretroviral Therapy in Neonates, Children, and AdolescentsMichael Neely, Andrea Kovacs
Clinical Pharmacokinetics|November 18, 2011
Obesity and its impact on drug therapy: are we ready for this change?Michael Neely, Stan Louie
Journal of Clinical Pharmacology|July 19, 2008
Practical therapeutic drug management in HIV-infected patients: use of population pharmacokinetic models supplemented by individualized Bayesian dose optimizationMichael Neely, Roger Jelliffe
Therapeutics and Clinical Risk Management|August 27, 2009
Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavirMichael Neely, Andrea Kovacs
Current Therapeutic Research, Clinical and Experimental|June 20, 2014
Pharmacokinetic characteristics of caspofungin in two pediatric liver transplant patientsMichael Neely, Jeffrey Blumer
Journal of Clinical Pharmacology|February 16, 2010
Practical, individualized dosing: 21st century therapeutics and the clinical pharmacometricianMichael Neely, Roger Jelliffe
Journal of Pharmacokinetics and Pharmacodynamics|December 3, 2016
Experiment design for nonparametric models based on minimizing Bayes Risk: application to voriconazole¹David S Bayard, Michael Neely
The Annals of Pharmacotherapy|August 25, 2011
Comment: assessment of vancomycin dosing and subsequent serum concentrations in pediatric patientsSylvain Goutelle, Michael Neely, Nathalie Bleyzac
Pageof 10